Oxaliplatin

CAS 61825-94-3 19 current records 7 historicalSmall Molecule

Who holds supplier records for Oxaliplatin? 19 organisations hold a current record for Oxaliplatin: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), China (4), Germany (1), Netherlands (1) and 3 other countries (3); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Oxaliplatin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/oxaliplatin

Reading the evidence

  • 19 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (19)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Oxaliplatin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Oxaliplatin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Oxaliplatin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 30 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HETERO LABS LIMITED HyderabadIN
CEP 2015-112 - Rev 02
Oxaliplatin
Jun 2026—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2024-552 - Rev 01
Oxaliplatin, Process-II
Mar 2026—
SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan CityCN
CEP 2013-113 - Rev 01
Oxaliplatin
Nov 2025—
DEBIOPHARM INTERNATIONAL S.A. LausanneCH
CEP 2003-229 - Rev 06
Oxaliplatin
Jun 2025—
HERAEUS PRECIOUS METALS GMBH & CO. KG HanauDE
CEP 2006-137 - Rev 06
Oxaliplatin, Process HER-2
Apr 2025Inspected Oct 2025
Germany
TAPI NL B.V. AmsterdamNL
CEP 2005-259 - Rev 04
Oxaliplatin
Mar 2025—
LAURUS LABS LIMITED HyderabadIN
CEP 2011-357 - Rev 04
Oxaliplatin, Process 2
Sept 2024—
KUNMING GUIYAN PHARMACEUTICAL CO., LTD. KunmingCN
CEP 2009-384 - Rev 03
Oxaliplatin
Aug 2024—
JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. LianyungangCN
CEP 2024-149 - Rev 00
Oxaliplatin, Process II
Aug 2024—
FRESENIUS KABI ONCOLOGY LIMITED KalyaniIN
CEP 2007-193 - Rev 06
Oxaliplatin
Jun 2024—
UMICORE ARGENTINA S.A. Pilar Industrial ParkAR
R0-CEP 2022-346 - Rev 00
Oxaliplatin, LB
Nov 2022—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
R1-CEP 2006-201 - Rev 02
Oxaliplatin
Jul 2022—
QILU PHARMACEUTICAL CO., LTD. JinanCN
R1-CEP 2010-071 - Rev 03
Oxaliplatin
Sept 2021—
CIPLA LIMITED MumbaiIN
R1-CEP 2007-296 - Rev 02
Oxaliplatin
Jul 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Oxaliplatin are no longer active. These show a past filing, not current supply.

Show all 7 historical records
  • China · Inactive DMF 27762 · filed Dec 2013
  • MAC CHEM PRODUCTS INDIA PVT LTD
    Inactive DMF 27028 · filed Apr 2013
  • Hubei Haosun Pharmaceutical Co., Ltd.
    China · Inactive DMF 26107 · filed May 2012
  • JARI PHARMACEUTICAL CO LTD
    Inactive DMF 25681 · filed Jan 2012
  • United States · Inactive DMF 24367 · filed Nov 2010
  • India · Inactive DMF 23101 · filed Sept 2009
  • POLYMED THERAPEUTICS INC
    Inactive DMF 20897 · filed Sept 2007

Overview

Oxaliplatin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL414804).

Chemical identity

IUPAC name
oxalate;platinum(2+);trans-(1R,2R)-cyclohexane-1,2-diamine
Canonical SMILES
C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2]
InChIKey
ZROHGHOFXNOHSO-BNTLRKBRSA-L
Synonyms
Eloxatin, JM-83, L-OHP, MBP-426 (LIPOSOMAL OXALIPLATIN), NSC-266046, Oxaliplatin, Oxaliplatin component of folfox, Oxaliplatin component of xelox, Oxaliplatine, Oxaliplatino, RP-54780, SR-96669

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Platinum-based Drug

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Oxaliplatin?

19 organisations hold an active US FDA Type II Drug Master File or a CEP for Oxaliplatin: KUNMING GUIYAN PHARMACEUTICAL CO LTD (China), HERAEUS PRECIOUS METALS GMBH AND CO KG (Germany), Hetero Labs Limited (India), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (China), Laurus Labs Limited (India), Qilu Pharmaceutical Co., Ltd. (China), SHILPA PHARMA LIFESCIENCES LTD (India) and Sun Pharmaceutical Industries Limited (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Oxaliplatin Drug Master Files are active?

KUNMING GUIYAN PHARMACEUTICAL CO LTD (DMF 41028, 29430), HERAEUS PRECIOUS METALS GMBH AND CO KG (DMF 19633), Hetero Labs Limited (DMF 28913), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (DMF 20665), Laurus Labs Limited (DMF 22387), Qilu Pharmaceutical Co., Ltd. (DMF 23530), SHILPA PHARMA LIFESCIENCES LTD (DMF 23563) and Sun Pharmaceutical Industries Limited (DMF 19648) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Oxaliplatin records mean?

7 organisations have only inactive Type II DMFs for Oxaliplatin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Oxaliplatin have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Oxaliplatin on the EDQM register, including HETERO LABS LIMITED Hyderabad (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan City (CN), DEBIOPHARM INTERNATIONAL S.A. Lausanne (CH), HERAEUS PRECIOUS METALS GMBH & CO. KG Hanau (DE) and TAPI NL B.V. Amsterdam (NL) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Oxaliplatin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Oxaliplatin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.